Algert Global LLC increased its position in shares of CorVel Corp. (NASDAQ:CRVL – Free Report) by 73.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 217,559 shares of the business services provider’s stock after acquiring an additional 92,077 shares during the quarter. Algert Global LLC owned about 0.42% of CorVel worth $16,843,000 at the end of the most recent quarter.
Several other hedge funds have also added to or reduced their stakes in the company. Alliancebernstein L.P. raised its holdings in CorVel by 40.5% during the 3rd quarter. Alliancebernstein L.P. now owns 51,012 shares of the business services provider’s stock worth $3,949,000 after purchasing an additional 14,710 shares during the last quarter. Ameriprise Financial Inc. boosted its stake in shares of CorVel by 8.3% in the 3rd quarter. Ameriprise Financial Inc. now owns 80,968 shares of the business services provider’s stock valued at $6,269,000 after purchasing an additional 6,193 shares during the last quarter. Schonfeld Strategic Advisors LLC boosted its stake in shares of CorVel by 246.5% in the 3rd quarter. Schonfeld Strategic Advisors LLC now owns 31,018 shares of the business services provider’s stock valued at $2,401,000 after purchasing an additional 22,066 shares during the last quarter. Creative Planning grew its position in shares of CorVel by 42.8% during the 3rd quarter. Creative Planning now owns 12,494 shares of the business services provider’s stock worth $967,000 after buying an additional 3,746 shares during the period. Finally, Raymond James Financial Inc. raised its stake in shares of CorVel by 1.3% during the third quarter. Raymond James Financial Inc. now owns 221,070 shares of the business services provider’s stock worth $17,115,000 after buying an additional 2,798 shares during the last quarter. Institutional investors own 51.36% of the company’s stock.
CorVel Stock Performance
Shares of NASDAQ CRVL opened at $52.63 on Friday. CorVel Corp. has a 52-week low of $44.83 and a 52-week high of $119.57. The stock has a market cap of $2.69 billion, a P/E ratio of 25.80 and a beta of 1.10. The firm has a 50 day moving average price of $58.39 and a 200 day moving average price of $69.44.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings restated a “hold (c)” rating on shares of CorVel in a report on Friday, January 9th. One analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock has an average rating of “Hold”.
Get Our Latest Stock Report on CorVel
CorVel Company Profile
CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.
The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).
Featured Articles
- Five stocks we like better than CorVel
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- A personal warning from Martin Weiss (Please read)
Want to see what other hedge funds are holding CRVL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CorVel Corp. (NASDAQ:CRVL – Free Report).
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.
